Target-Bound Generated Pharmacophore Model to Improve the Pharmacophore-Based Virtual Screening: Identification of G-Protein Coupled Human CCR2 Receptors Inhibitors as Anti-Inflammatory Drugs
- 313 Downloads
Pharmacophore-based virtual screening is being widely used to discover new drug candidates. Building a pharmacophore model based on a known inhibitor that is unbound to the target could be misleading and result in mining for the wrong hits. Results presented herein confirm that pharmacophore models based on unbound and bound ligand confirmations produce significantly, structurally different compound libraries and, consequently, change the outcome of the virtual screening. To further verify our findings, molecular dynamics and extensive post-dynamic analysis are performed for the best retrieved hits from each approach; these are the unbound and bound ligand pharmacophore-generated libraries. In this report, the proposed target-bound pharmacophore model is used to discover potential G-protein coupled CCR2 receptor inhibitors as potential anti-inflammatory drugs. Herein, various molecular modeling approaches are adopted including homology modeling, molecular docking, lipid bilayer molecular dynamics simulations and per-residue interaction energy decomposition analysis. The current study highlights some critical aspects in the pharmacophore-based virtual screening as a powerful tool in the drug discovery and development machinery.
KeywordsHomology modeling Pharmacophore-based virtual screening Molecular dynamic Lipid bilayer modeling
The authors would like to thank the School of Health Sciences, UKZN for financial support and the Center for High Performance Computing (www.chpc.ac.za) for computational resources.
- 9.Frisch, M. J., G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, et al. Gaussian 03, Revision E.01. Wallingford, CT: Gaussian Inc., 2004.Google Scholar
- 19.Jaen, J. C., J. P. Powers, and T. Sullivan. Type-2 diabetes and associated comorbidities as an inflammatory syndrome. In: Annual Reports in Medicinal Chemistry, Vol. 47, edited by M. C. Desai. San Diego: Elsevier, 2012, pp. 159–175.Google Scholar
- 20.Jain, A. N. Virtual screening in lead discovery and optimization. Curr. Opin. Drug Discov. Dev. 7:396–403, 2004.Google Scholar
- 30.Sanner, M. F. Python: a programming language for software integration and development. J. Mol. Graph. Model. 17(1):57–61, 1999.Google Scholar
- 39.Trott, O., and A. J. Olson. Software news and update Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2):455–461, 2010.Google Scholar
- 40.Vogt, M., and J. Bajorath. Data mining approaches for compound selection and iterative screening. In: Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery, edited by K. V. Balakin. Hoboken, NJ, USA: John Wiley & Sons, 2009, pp. 115–143.Google Scholar
- 42.Wallace, A. C., R. A. Laskowski, and J. M. Thornton. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8:127–134, 1996.Google Scholar
- 43.Wang, H. Y., et al. LPS induces cardiomyocyte injury through calcium-sensing receptor. Mol. Cell. Biochem. 379(1–2):153–159, 2013.Google Scholar